The Latest Cancer Drugs News
Browsing: Cancer Drug News
Neoadjuvant combination checkpoint blockade trial yields high response rates for patients with high-risk stage three melanoma
Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with…
Anti-psychotic drug could treat aggressive breast cancer
A commonly-used anti-psychotic drug could also be effective against triple negative breast cancer, the form…
Breast cancer drug could be used to treat life-threatening leukaemia
A recently-approved breast cancer drug could be used to target and treat a life-threatening leukaemia,…
Health-related quality of life overlooked in cancer drug studies
A McMaster University-led review and analysis of randomised clinical trials is questioning whether interventions which…
New approach on the use of big data in clinical decision support
A new computational approach that allows the identification of molecular alterations associated with prognosis and…
CHMP announched positive opinion for brigatinib as treatment of ALK positive NSCLC in patients previously treated with crizotinib
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive…
FDA approves duvelisib for adult patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma
The Food and Drug Administration has granted regular approval to duvelisib for adult patients with relapsed…
Anti-inflammatory use during surgery could improve cancer outcomes
The world’s first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in…
Keeping cancer out of breath blocks drug resistance
A new combination of existing drugs shows promise that it could reduce the size of…
Experimental drug takes aim at cancers associated with Epstein-Barr virus
Epstein-Barr Virus (EBV) doesn’t directly cause cancer, but infection with this common herpes virus brings…